retatrutide pharmacy Retatrutide. The next evolution. A next-generation triple agonist designed to advance metabolic research through GLP-1, GIP, and glucagon receptor pathways. Supporting innovation through trusted peptide sourcing. For healthcare professionals. Research How Retatrutide Works

Within research on weight loss, appetite regulation and energy expenditure , Retatrutide is often compared to known GLP-1 peptides, but with broader receptor activity

& Tanner, C

As of November 2025, nearly 80% (77.8%) of all Microdose GLP-1Rx users stayed engaged with the Noom app for 4 or more weeks, and D30 engagement for our December cohort was over 40% (43.6%), 1 which is at least 10 times higher than average health, medical, and fitness app retention

A photo accompanying this announcement is available at SOURCE: MORINGA MAGIC MATTHEW PHODEN [email protected] (888) 456-5640

5 Lower doses: Eight in ten real-world patients were on maintenance doses below 1.7 mg of semaglutide or 10 mg of tirzepatide

May your medications stay properly dosed, your monitoring stay consistent, and your weight loss journey stay safe.